10 Sources of evidence
The following documentation and opinions were made available to the committee:
a) Assessment report: The effectiveness of inhaler devices for young children with asthma; Prepared by Payne N and Beard S, Trent Institute for Health Services Research, School of Health and Related Research, University of Sheffield; Wright, Brocklebank, D and Ram F, Bradford Hospitals NHS Trust; Taylor RS, National Institute for Clinical Excellence. March 2000.
b) Manufacturer or sponsor submissions:
-
AstraZeneca
-
Boehringer Ingelheim Ltd.
-
Aventis Pharma (formerly Rhône-Poulenc Rorer)
-
Boehringer Ingelheim Ltd.
-
Glaxo Wellcome
-
3M Health Care Ltd.
-
Norton Healthcare
-
Yamanouchi Pharma Ltd
c) Professional or specialist group, patient or carer group and trade association submissions:
-
Association of British Health-Care Industries
-
British Medical Association
-
British Thoracic Society
-
National Asthma Campaign
-
Royal College of Nursing
-
Royal College of Paediatrics and Child Health
-
Royal College of Physicians
The following experts were invited to make submissions to the Committee:
-
Dr Andrew Bush, Reader in paediatric respirology and honorary consultant paediatric chest physician, Royal Brompton Hospital, London.
-
Dr C O'Callaghan, Senior lecturer and consultant paediatrician, University of Leicester and Leicester Royal Infirmary Children's Hospital.
ISBN: 978-1-4731-5664-7